株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

欧州のがん診断市場の分野別分析:発がん遺伝子、生化学的マーカー、リンフォカイン、増殖因子(GF)、コロニー刺激因子(CSF)、ホルモン、免疫組織化学的染色−−病院・民間試験所・POC(ポイントオブケア)向け需要

Europe Cancer Diagnostics Market Segmentation Analysis: Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

発行 Venture Planning Group 商品コード 309623
出版日 ページ情報 英文 820 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。

Local License: 同一事業所内

Back to Top
欧州のがん診断市場の分野別分析:発がん遺伝子、生化学的マーカー、リンフォカイン、増殖因子(GF)、コロニー刺激因子(CSF)、ホルモン、免疫組織化学的染色−−病院・民間試験所・POC(ポイントオブケア)向け需要 Europe Cancer Diagnostics Market Segmentation Analysis: Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
出版日: ページ情報: 英文 820 Pages
概要

当レポートでは、欧州主要5ヶ国(フランス・ドイツ・イタリア・スペイン・英国)におけるがん診断市場における今後のビジネス機会について分析し、現在/将来の検査技術の概要や、今後の技術開発の見通し・方向性、地域全体および国別・製品セグメント別の市場動向、主要企業のプロファイル、サプライヤー各社にとっての市場機会などを調査・考察しております。

第1章 イントロダクション

第2章 欧州市場の概況

  • 市場概要
  • 欧州市場の構造
  • 欧州市場の規模・成長率

第3章 主要製品の開発機会

  • 試薬キットおよび検査システム/パネル
  • 診断装置
  • コンピューター・ソフトウェア・自動化
  • 補助製品

第4章 分散型検査製品の設計基準

第5章 代替的な市場普及戦略

第6章 潜在的な市場参入障壁とリスク

第7章 世界の市場・技術の概要

  • 現在・将来の主ながん診断検査
    • 生化学腫瘍マーカー
    • 発がん遺伝子
    • ポリペプチド増殖因子
    • 異所性ホルモン
    • コロニー刺激因子
    • リンフォカイン
    • 免疫組織化学的染色(ステイン)
    • 新規の腫瘍マーカー
  • 診断装置の分析と市場ニーズ
  • 現在・将来の技術
  • 個別化検査

第8章 フランス市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場の動向・傾向・規模・成長率
    • 市場規模の予測:検査項目・市場セグメント別
    • 売上高の予測:検査項目・市場セグメント別
    • 主要サプライヤーの売上高・市場シェア

第9章 ドイツ市場

第10章 イタリア市場

第11章 スペイン市場

第12章 英国市場

第13章 企業プロファイル

  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • 栄研化学
  • Epigenomics
  • Enterix
  • Enzo Biochem
  • Exact Sciences
  • 富士レビオ/Innogenetics
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech
  • 協和メデックス
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen/Ipsogen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • タカラバイオ
  • Targeted Diagnostics & Therapeutics
  • Thermo Fisher/Life Technologies
  • 東ソー
  • Veridex
  • 和光純薬工業
  • Wallac/PE
  • Zila

第14章 付録:がん診断技術とその活用方法を開発している主な大学・研究機関

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCA20236

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

This new report from VPGMarketResearch.com is based on a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in the European market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Geographic Coverage

France, Germany, Italy, Spain, UK

European Market Overview

- Five-year test volume and sales projections by country.

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.

- Estimated universe of laboratories performing cancer diagnostic testing by country.

- Cancer statistics, etiology and recent developments in Europe.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Oncogenes Biochemical Markers Growth Factors Colony Stimulating Factors Hormones Immunohistochemical Stains Lymphokines

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers by individual test and country.

- Five-year test volume and sales forecasts for major tumor markers by country and market segment, including:

     º  Hospitals      º  Commercial/Private Laboratories      º  Physician Offices/Group Practices

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies.

- Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott    - AdnaGen    - Agilent Technologies    - Applied Gene Technologies    - Arca Biopharma    - Beckman Coulter/Danaher    - Becton Dickinson    - Biomedical Diagnostics    - bioMerieux    - Bio-Rad    - CellSearch    - Cepheid    - Correlogic Systems/Vermillion    - Decode Genetics    - Diadexus    - Diagnocure    - DiaSorin    - Eiken Chemical    - Elitech Group    - Enterix    - Enzo Biochem    - Epigenomics    - Exact Sciences    - Fujirebio    - Guided Therapeutics    - Hologic/Gen-Probe    - Kreatech/Leica    - Kyowa Medex    - Mackay Life Sciences    - Myriad Genetics    - OncoLab    - Ortho-Clinical Diagnostics    - Panacea Pharmaceuticals    - Polartechnics    - Polymedco    - PreMD    - Qiagen    - Quest Diagnostics    - Radient Pharmaceuticals    - Roche    - Scienion    - Sequenom    - Siemens Healthcare    - Takara Bio    - Targeted Diagnostics & Therapeutics    - Thermo Fisher    - Tosoh    - Veridex    - Wako Pure Chemicals    - Wallac/PE    - Zilla

Contains 820 pages and 320 tables

Table of Contents(PARTIAL)*

I. Introduction

II. European Market Overview

  • A. Market Overview
  • B. European Market Structure
  • C. European Market Size and Growth

III. Major Product Development Opportunities

  • A. Reagent Kits and Test Systems/Panels
  • B. Instrumentation
  • C. Computers, Software and Automation
  • D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Worldwide Market and Technology Overview

  • A. Major Current and Emerging Cancer Diagnostic Tests
    • 1. Biochemical Tumor Markers
    • 2. Oncogenes
    • 3. Polypeptide Growth Factors
    • 4. Ectopic Hormones
    • 5. Colony Stimulating Factors
    • 6. Lymphokines
    • 7. Immunohistochemical Stains
    • 8. Emerging Tumor Markers
  • B. Instrumentation Review and Market Needs
  • C. Current and Emerging Technologies
  • D. Personal Testing

VIII. France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

IX. Germany

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

X. Italy

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XI. Spain

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XII. U.K.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XIII. Competitive Profiles

  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Epigenomics
  • Enterix
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio/Innogenetics
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech
  • Kyowa Medex
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen/Ipsogen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Thermo Fisher/Life Technologies
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

XIV. Appendix: Major Universities and Research

  • Centers Developing Cancer Diagnostic Technologies and Applications

List of Tables

  • Cancer Diagnostic Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications In Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis
  • Executive Summary Table: France, Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
  • France, Estimated Cancer Death Rates
  • France, Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • France, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • France, Commercial/Private Laboratories Performing Cancer Diagnostic Test by Annual Test Volume
  • France, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
  • France, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
  • France, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
  • France, Commercial/Private Laboratories Marker Test Volume Forecasts
  • France, Total Cancer Diagnostic Sales Major Cancer Diagnostic Forecasts by Market Segment
  • France, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
  • France, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • France, Commercial/Private Laboratories Cancer Diagnostic Market Forecasts by Test
  • France, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market
  • France, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
  • France, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecasts by Market Segment
  • France, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Nucleolar Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Progesterone Receptor Test Volume And Diagnostics Sales Forecasts by Market Segment
  • France, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecasts by Market Segment
  • France, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Thymidine Kinase Test Volume And Diagnostics Sales Forecasts by Market Segment
  • France, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Total Cancer Diagnostics Sales By Major Suppliers
  • France, AFP Testing Market Diagnostics Sales by Major Supplier
  • France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • France, CEA Testing Market Diagnostics Sales by Major Supplier
  • France, NSE Testing Market Diagnostics Sales by Major Supplier
  • France, PAP Testing Market Diagnostics Sales by Major Supplier
  • France, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Germany, Total
  • Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment
  • Germany, Estimated Cancer Death Rates
  • Germany, Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • Germany, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • Germany, Commercial/Private Laboratories Performing Cancer Diagnostic Tests by Annual Test Volume
  • Germany, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
  • Germany, All Market Segments, Major Cancer Diagnostic Test Volume Forecasts by Test
  • Germany, Hospital Laboratories, Major Cancer Diagnostic Test Volume Forecasts by Test
  • Germany, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • Germany, Physician Offices/Group Practices Major Cancer Diagnostic Test Volume Forecasts
  • Germany, Total Cancer Diagnostic Sales Forecasts by Market Segment
  • Germany, All Market Segments Major Tumor Marker Sales Forecasts by Test
  • Germany, Hospital Laboratories, Major Tumor Marker Sales Forecasts by Test
  • Germany, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • Germany, Physician Offices/Group Practices Major Cancer Diagnostic Sales Forecasts by Test
  • Germany, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, CA-19 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, CA 125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Calcitonin Test Volume And Diagnostic Sales Forecasts by Market Segment
  • Germany, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Chromogranin Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Germany, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Germany, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, HCG, Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Germany, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
  • Germany, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Total Cancer Diagnostics Sales By Major Supplier
  • Germany, AFP Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CEA Testing Market Diagnostics Sales by Major Supplier
  • Germany, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Italy, Total Cancer Diagnostic Testing Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Estimated Cancer Death Rates
  • Italy, Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • Italy, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • Italy, Commercial/Private Laboratories Performing Cancer Diagnostics Tests By Annual Test Volume
  • Italy, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
  • Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
  • Italy, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • Italy, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • Italy, Total Cancer Diagnostic Test Market Forecasts by Market Segment
  • Italy, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
  • Italy, Hospital Laboratories Major Cancer Diagnostic Forecasts by Test
  • Italy, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • Italy, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, CA-19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, CA 125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Chromogranin Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Italy, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Italy, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
  • Italy, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, S-100 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
  • Italy, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Total Cancer Diagnostics Sales by Major Suppliers
  • Italy, AFP Testing Market Diagnostics Sales by Major Supplier
  • Italy, CEA Testing Market Diagnostics Sales by Major Supplier
  • Italy, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Spain, Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
  • Spain, Estimated Cancer Death Rates
  • Spain, Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • Spain, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • Spain, Commercial/Private Laboratories Performing Cancer Diagnostics Tests By Annual Test Volume
  • Spain, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
  • Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecasts
  • Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
  • Spain, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • Spain, Total Cancer Diagnostic Sales Forecasts by Market Segment
  • Spain, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
  • Spain, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • Spain, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • Spain, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, CA 15-3 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts By Market Segment
  • Spain, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, S-100 Protein Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Spain, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Total Cancer Diagnostics Sales By Major Suppliers
  • Spain, AFP Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CEA Testing Market Diagnostics Sales by Major Supplier
  • Spain, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: U.K., Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
  • U.K., Estimated Cancer Death Rates
  • U.K., Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • U.K., Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • U.K., Commercial/Private Laboratories Performing Cancer Diagnostic Tests By Annual Test Volume
  • U.K., Total Cancer Diagnostic Testing Volume Forecasts by Market Segment
  • U.K., All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
  • U.K., Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts By Test
  • U.K., Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • U.K., Total Cancer Diagnostic Sales Forecasts by Market Segment
  • U.K., All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
  • U.K., Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • U.K., Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • U.K., ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment
  • U.K., Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Total Cancer Diagnostics Sales and Market Shares Forecasts
  • U.K., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.K., PSA Testing Market Diagnostics Sales by Major Supplier

*[Complete Table of Contents available upon request]

Back to Top